RNA Therapeutics Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

RNA Therapeutics Market is Segmented By Type of Modality (RNA Therapeutics, RNA Vaccines), By Type of Molecule (Replicating RNA (repRNA), Self amplifying RNA (saRNA), Self activating RNA (sacRNA), Self activating mRNA (samRNA), Transfer RNA (tRNA)). The report offers the value (in USD million) for the above-mentioned segments.

RNA Therapeutics Market is Segmented By Type of Modality (RNA Therapeutics, RNA Vaccines), By Type of Molecule (Replicating RNA (repRNA), Self amplify....

RNA Therapeutics Market Size

Market Size in USD

CAGR68%

Study Period	2024-2031
Base Year of Estimation	2023
CAGR	68%
Market Concentration	Medium
Major Players	Alphavax, Arcturus Therapeutics, Atyr Pharma, Gritstone Bio, HDT Bio

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

RNA Therapeutics Market Analysis

The RNA Therapeutics Market is estimated to be valued at USD 2.5 Mn in 2024 and is expected to reach USD 948 Mn by 2031, growing at a compound annual growth rate (CAGR) of 68% from 2024 to 2031.

The RNA therapeutics market is witnessing positive growth trends over the past few years. Factors such as increasing investment in RNA-based drug development, growing focuses on rare diseases and genetic disorders, rising prevalence of infectious diseases and cancer are expected to drive the demand for RNA therapeutics during the forecast period.

RNA Therapeutics Market Report Snapshots

Buy Now